New fluorescent methoxylated di(hetero)arylethers in the thieno [3,2-b] 
Introduction
Thienopyridine derivatives including di(hetero)arylethers have attracted much attention because of their potential different biological activities namely as antitumoral agents [1] , nonreceptor Src kinase inhibitors [2] and receptor tyrosine kinase inhibitors [3, 4, 5] .
Nanoliposomes are new technological developments for the encapsulation and delivery of bioactive agents. Because of their biocompatibility and biodegradability, along with their size, nanoliposomes have potential applications in a vast range of fields, including nanotherapy.
Nanoliposomes are able to enhance the performance of bioactive agents by improving their bioavailability, in vitro and in vivo stability, as well as preventing their unwanted interactions with other molecules [6] . They may contain, in addition to phospholipids, other molecules such as cholesterol (Ch) which is an important component of most natural membranes. The incorporation of Ch may increase the stability by modulating the fluidity of the lipid bilayer preventing crystallization of the phospholipid acyl chains and providing steric hindrance to their movement. Further advances in liposome research found that polyethylene glycol (PEG), which is inert in the body, allows longer circulatory life of the drug delivery system [7] .
In this work we describe the synthesis of new fluorescent di(hetero)arylethers in the thieno [3,2-b] pyridine series, by copper-catalyzed Ullmann-type C-O coupling of the methyl 3-amino-6-bromo-thieno [3,2-b] pyridine-2-carboxylate, earlier prepared by us [8] , with o-, mand p-methoxyphenols. The effects of the three coupling products obtained in the growth inhibition of human tumor cell lines, MCF-7 (breast adenocarcinoma), A375-C5 (melanoma), NCI-H460 (non-small cell lung cancer), were evaluated and the ortho and metamethoxydi(hetero)arylethers were shown to be the most promising antitumor compounds, presenting very low GI 50 values in all the cell lines studied. For the latter compounds, the fluorescence properties were evaluated in different solvents and when encapsulated in different nanoliposome formulations, with or without cholesterol and PEG. Fluorescence anisotropy measurements can give relevant information about the compound behavior and location in the several liposomes, namely if they are located in the lipid bilayer, feeling the differences between the gel and the liquid-crystalline phases of phospholipids. These studies are important keeping in mind future drug delivery applications of these new potential anticancer drugs.
Experimental

Synthesis
2.1.1.General Remarks
Melting points ( o C) were determined in a SMP3 Stuart apparatus and are uncorrected. 1 H and 13 C NMR spectra were recorded on a Bruker Avance III at 400 and 100.6 MHz, respectively. Heteronuclear correlations, 1 H- 13 C, HMQC or HSQC were performed to attribute some signals.
MS and HRMS data were recorded using a method of direct injection by EI (70eV) and by the mass spectrometry service of the University of Vigo, Spain. 
Solutions of the compounds
Stock solutions of the tested compounds were prepared in DMSO and kept at −70°C.
Appropriate dilutions were freshly prepared in the test medium just prior to the assays. The effect of the vehicle solvent (DMSO) on the growth of the cell lines was evaluated by exposing untreated control cells to the maximum concentration of DMSO used in the assays (0.25%). No influence was found (data not shown).
Cell cultures
Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and A375-C5 (melanoma) were used. MCF-7 and A375-C5 were obtained from the European Collection of Cell Cultures (ECACC, Salisbury, UK), and NCI-H460 was kindly provided by the National Cancer Institute (NCI, Bethesda, USA). They were routinely maintained as adherent cell cultures in RPMI-1640 medium supplemented with 5% heatinactivated FBS, 2 mM glutamine and antibiotics (penicillin 100 U/mL, streptomycin 100 µg/mL), at 37°C in a humidified atmosphere containing 5% CO 2 . Exponentially growing cells were obtained by plating 1.5×10 5 cells/mL for MCF-7 and 0.75×10 5 cells/mL for A375-C5
and NCI-H460, followed by a 24 h incubation.
Cell growth inhibition assay
The effects on the in vitro growth of human tumor cell lines were evaluated according to the procedure adopted by the NCI (USA) in their "In vitro Anticancer Drug Discovery Screen", using the protein-binding dye sulforhodamine B to assess cell growth [9, 10] . Briefly, exponentially growing cells were exposed for 48 h, in 96-well microtiter plates, to five serial dilutions of each test compound, starting from a maximum concentration of 150 µM (if possible). Following the exposure period adherent cells were fixed in situ, washed and stained with SRB. The bound stain was solubilized and the absorbance was measured at 492 nm in a plate reader (Biotek Instruments Inc., Powerwave XS, Wincoski, USA). Dose-response curves were obtained for each test compound and cell line, and the growth inhibition of 50% (GI 50 ), corresponding to the concentration of the compounds that inhibited 50% of the net cell growth was calculated as described elsewhere [10] . Doxorubicin was tested in the same manner to be used as a positive control.
Liposomes preparation
All the solutions were prepared using spectroscopic grade solvents and ultrapure water 
Nanoliposomes were prepared by evaporation of a mixture of lipids and compound in chloroform under vacuum for 12 h. The lipid/compound film was then hydrated with an aqueous buffer solution (10 mM Tris-HCl buffer, pH=7.4), above the lipids melting transition temperature (ca. 41 ºC for DPPC [11] , 23 ºC for DMPG [12] , 55 ºC for DSPC [13] and 45 ºC for DODAB [14] ), followed by six extrusion cycles (using a LIPEX TM extruder) through 100 nm polycarbonate membranes. Between the extrusion cycles, the solutions were allowed to equilibrate for 1 h. The final total lipid concentration was 1 mM, with a compound/lipid molar ratio of 1:333.
DLS and zeta potential measurements:
Liposomes mean diameter and size distribution (polydispersity index) were measured using a Dynamic Light Scattering (DLS) equipment (NANO ZS Malvern Zetasizer), at 25 ºC, using a He-Ne laser of 633 nm and a detector angle of 173º. Five independent measurements were performed for each sample. Malvern Dispersion Technology Software (DTS) was used with multiple narrow mode (high resolution) data processing, and mean size (nm) and error values were considered.
Spectroscopic measurements
Absorption spectra were recorded in a Shimadzu UV-3101PC UV-Vis-NIR spectrophotometer. Fluorescence measurements were performed using a Fluorolog 3 spectrofluorimeter, equipped with double monochromators in both excitation and emission, Glan-Thompson polarizers and a temperature controlled cuvette holder. Fluorescence spectra were corrected for the instrumental response of the system.
For fluorescence quantum yield determination, the solutions were previously bubbled for 20 minutes with ultrapure nitrogen. The fluorescence quantum yields (Φ s ) were determined using the standard method (equation 1) [15, 16] . Quinine sulfate in H 2 SO 4 0.05 M was used as reference, Φ r = 0.546 at 25 ºC [17] .
where A is the absorbance at the excitation wavelength, F the integrated emission area and n the refraction index of the solvents used. Subscripts refer to the reference (r) or sample (s)
compound. The absorbance value at excitation wavelength was always less than 0.1, in order to avoid inner filter effects. Solvatochromic shifts can be described by the Lippert-Mataga equation (2), which relates the energy difference between absorption and emission maxima to the orientation polarizability, [18, 19] const f hcR ) where abs ν is the wavenumber of maximum absorption, fl ν is the wavenumber of maximum emission, ∆µ = µe -µ g is the difference in the dipole moment of solute molecule between excited (µe) and ground (µg) states, R is the cavity radius (considering the fluorophore a point dipole at the center of a spherical cavity immersed in the homogeneous solvent), and f ∆ is the orientation polarizability given by (eq. 3):
where ε is the static dielectric constant and n the refractive index of the solvent.
An alternative expression, proposed by Bakhshiev, takes into account the angle, γ, between the ground and excited state dipole moments of the fluorophore [20, 21] : 
The steady-state fluorescence anisotropy, r, is calculated by
where I VV and I VH are the intensities of the emission spectra obtained with vertical and 
Biological activity
The effects of the di(hetero)arylethers 2a-c on the human tumor cells growth were evaluated in three human tumor cell lines MCF-7 (breast adenocarcinoma), A375-C5 (melanoma), NCI-H460 (non-small cell lung cancer) and the results are presented in Table 1 Doxorubicin, used as positive control, presents very high citotoxicity in these cell lines but it is also very toxic for the human body and nowadays is used in a liposomal pegylated formulation that decreases their toxicity and adverse secundary effects and increases the captation by the tumor [26] [27] [28] . Due to the antitumoral potential of the di(hetero)arylethers 2a-b and as both are fluorescent, their photophysical properties were studied. Also, their encapsulation in nanoliposomes for future drug delivery purposes was monitored using the intrinsic fluorescence of the compounds.
Fluorescence studies in several solvents
The absorption and fluorescence properties of compounds 2a and 2b were studied in several solvents ( Table 2 ). The normalized fluorescence spectra of both compounds are shown in Figures 1 and 2 , respectively. Examples of absorption spectra are shown as insets.
Compounds 2a and 2b exhibit reasonable fluorescence in several solvents. Fluorescence quantum yield values are in the range of 3% in chloroform and 34% in DMSO for compound 2a and of 2% (chloroform) and 29% (DMSO) for compound 2b (Table 2) . However, no emission is observed in protic solvents, like water or ethanol. This behaviour can be due to For both compounds, significant red shifts are observed for emission in polar solvents (50 nm between cyclohexane and dimethylsulfoxide for compound 2a and 52 nm for 2b). In the absorption spectra, the red shifts are negligible ( Table 2 ), indicating that solvent relaxation after photoexcitation plays an important role. In polar solvents, a clear band enlargement in emission is also observed (Figs. 1 and 2) , which is usually related to an intramolecular charge transfer (ICT) mechanism and/or to specific solvent effects [18] .
The solvatochromic plots for compounds 2a-b, shown in Figure 3 , are reasonably linear, the slope being larger for compound 2b. This shows that the presence of the methoxy group in the meta position causes an enhance of the ICT character of the excited state. From ab initio molecular quantum chemistry calculations, obtained with Gaussian 09 software [31] and use of a 6-311+G(dp) basis set at the TD-SCF DFT (B3LYP) level of theory [32] in gas phase, the cavity radius (R) and the ground state dipole moment (µg) were determined for the two compounds ( Table 3 ). The optimized geometry of the ground state of the di(hetero)arylethers 2a-b shows that the methoxyphenyl moiety is completely out of the plane of the thienopyridine system. In the lowest excited state a distortion occurs, which is much more pronounced in compound 2b, where the two moieties are further apart (Figure 4 ).
The directions of the calculated dipole moments in the ground and excited state are also indicated in Figure 4 , evidencing a change in the excited state dipole moment vector to almost the opposite direction relative to the ground state one. This clearly indicates that the angle between the two dipole moment vectors cannot be neglected and must be considered in the solvatochromic plots (Bakhshiev's equation (4)). The absolute value of the difference in the excited and ground state dipole moment vectors, estimated from the solvatochromic plots ( Figure 3 ) and from molecular quantum mechanical calculations, are presented in Table 3 . The obtained values are similar and, therefore, both methods point to the presence of a significant charge transfer mechanism in the excited state, more pronounced for compound 2b. Table 3 . Cavity radius (R), ground (µg) and excited state (µe) dipole moments obtained from theoretical calculations, and absolute value of the dipole moment difference ( The photophysical behavior of both compounds shows that they can be considered as solvatochromic probes. The significant sensitivity of the fluorescence emission to the fluorophore environment can be very useful when probing the location/behavior of these compounds in liposomes.
Fluorescence studies in nanoliposomes
Fluorescence experiments of both compounds encapsulated in liposomes of several compositions were carried out. These liposomes were composed either by neat phospholipids, or by phospholipid mixtures, with or without cholesterol (Ch) and PEG. Several different lipid compositions were studied, keeping in mind future drug delivery applications of 2a and 2b as potential anticancer drugs. Table 4 ). In DODAB and DMPG aggregates, a band enlargement and a shift to higher emission wavelengths is observed, indicating a more hydrated environment for the compounds in these aggregates. The red shift is more significant for both compounds in DMPG aggregates, which can be explained by the formation of DMPG unilamellar vesicles with perforations [34] , or leaky vesicles [35] , where the compounds may feel more penetration of water molecules. Fluorescence anisotropy (r) measurements (Table 4) can give relevant information about the location of the compounds in liposomes, as r increases with the rotational correlation time of the fluorescent molecule (and, thus, with the viscosity of the fluorophore environment) [36] .
Anisotropy values in a viscous solvent (glycerol) were also determined, for comparison.
Steady-state fluorescence anisotropy results ( Table 4 Considering future developments of these compounds delivery using nanoliposomes as drug carriers, several different liposome formulations were prepared [37] [38] [39] , some of them containing cholesterol (Ch) and polyethylene glycol (PEG). The incorporation of Ch may increase the stability by modulating the fluidity of the lipid bilayer, preventing crystallization of the phospholipid acyl chains and providing steric hindrance to their movement. Further advances in liposome research found that PEG, which is inert in the body, allows longer circulatory life of the drug delivery system [7] .
Previous studies have shown that DODAB-based liposomes exhibit very large sizes (diameter larger than 250 nm) [39] [40] [41] and, for this reason, this cationic lipid was not used in the liposome formulations prepared. On the contrary, most of the nanoliposomes contain DMPG, as the presence of pores across this lipid membrane has a promising biological relevance in applications for controlled release from nanocompartments [34] .
The size and size distribution (polydispersity index) of the prepared nanoliposomes with encapsulated compounds 2a and 2b were obtained by DLS. All the liposomes have a mean hydrodynamic diameter lower than 140 nm and generally low polydispersity ( formulations allowed us to obtain the smaller nanoliposome diameters, which are lower than 100 nm for both compounds. The Egg-PC:Ch formulation is the one with a lower polydispersity. The two compounds show significant fluorescence emission when incorporated in nanoliposomes ( Figure 7 ) and steady-state fluorescence anisotropy values are generally high at room temperature (Table 6 ). Upon increasing temperature, both compounds exhibit a significant decrease in fluorescence anisotropy (Table 6) , feeling an increase in fluidity of the nanoliposome membranes at high temperature. Therefore, both compounds are mainly located in the nanoliposome membranes.
The decrease in r values at 50 ºC is low in DSPC:DMPG (5:1) vesicles, due to the higher melting transition temperature of DSPC (T m = 55 ºC [13] ), as this phospholipid is still in the gel phase at 50 ºC. This fact can also contribute to the more hydrated environment reported by these compounds in DSPC:DMPG liposomes, as the rigidity of these membranes can prevent the compounds to penetrate more deeper in the lipid membranes. Overall, these results indicate that both compounds can be transported in the hydrophobic region of the lipid bilayers.
Conclusions
New fluorescent methoxylated di(hetero)aryl ethers in the thieno [3,2-b] pyridine series, 2a-c,
were prepared by a copper-catalyzed Ullmann-type C-O coupling in moderate to good yields, using an amino acid as the ligand.
Cell growth inhibition assays showed that compounds 2a and 2b are promising as antitumoral drugs, presenting very low GI 50 values in the three human tumor cell lines tested.
Both compounds have reasonable fluorescence quantum yields and can be considered as solvatochromic probes.
Our experimental results in nanoliposomes suggest that both compounds can be transported in the hydrophobic region of the lipid bilayer. The Egg-PC:Ch (7:3), Egg-PC:Ch:DMPG (7:3:1) and DSPC:Ch:DSPE-PEG2000 (1:1:0.75) nanoliposomes are the best formulations for encapsulation of these thienopyridines, considering the size (diameter lower than 100 nm) and polydispersity. These results may be important for future drug delivery applications of these new potential antitumoral aryletherthienopyridines, using nanoliposomes as drug carriers.
